Literature DB >> 23913628

Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague.

Wei Sun1, Joseph Olinzock, Shifeng Wang, Shilpa Sanapala, Roy Curtiss.   

Abstract

Yersinia pestis YadB and YadC are two new outer membrane proteins related to its pathogenicity. Here, codon-optimized yadC, yadC810 (aa 32-551), or yadBC antigen genes delivered by live attenuated Salmonella strains are evaluated in mice for induction of protective immune responses against Y. pestis CO92 through subcutaneous or intranasal challenge. Our findings indicate that mice immunized with Salmonella synthesizing YadC, YadC810, or YadBC develop significant serum IgG responses to purified recombinant YadC protein. For subcutaneous challenge (approximately 230 LD50 of Y. pestis CO92), mice immunized with Salmonella synthesizing YadC or YadC810 are afforded 50% protection, but no protection by immunization with the Salmonella strain synthesizing YadBC. None of these antigens provided protection against intranasal challenge (approximately 31 LD50 of Y. pestis CO92). In addition, subcutaneous immunization with purified YadC810 protein emulsified with alum adjuvant does not elicit a protective response against Y. pestis administered by either challenge route.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  Protective response; YadC; Yersinia pestis; bubonic plague; live attenuated Salmonella vaccine; pneumonic plague

Mesh:

Substances:

Year:  2013        PMID: 23913628      PMCID: PMC4028040          DOI: 10.1111/2049-632X.12076

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  69 in total

1.  Biochemical and cytochemical evidence for the polar concentration of periplasmic enzymes in a "minicell" strain of Escherichia coli.

Authors:  H F Dvorak; B K Wetzel; L A Heppel
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

2.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

3.  Th1 dominance in the immune response to live Salmonella typhimurium requires bacterial invasiveness but not persistence.

Authors:  A Pashine; B John; S Rath; A George; V Bal
Journal:  Int Immunol       Date:  1999-04       Impact factor: 4.823

4.  Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA.

Authors:  Ascención Torres-Escobar; María Dolores Juárez-Rodríguez; Christine G Branger; Roy Curtiss
Journal:  Vaccine       Date:  2010-07-13       Impact factor: 3.641

5.  Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa.

Authors:  Estela M Galván; Manoj Kumar Mohan Nair; Huaiqing Chen; Fabio Del Piero; Dieter M Schifferli
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

6.  Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.

Authors:  Huoying Shi; Javier Santander; Karen E Brenneman; Soo-Young Wanda; Shifeng Wang; Patti Senechal; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

7.  A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.

Authors:  Yuhua Li; Shifeng Wang; Wei Xin; Giorgio Scarpellini; Zhaoxing Shi; Bronwyn Gunn; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

8.  Potential for rat plague from nonencapsulated variants of the plague bacillus (Yersinia pestis).

Authors:  J E Williams; D C Cavanaugh
Journal:  Experientia       Date:  1984-07-15

9.  Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.

Authors:  Yuhua Li; Shifeng Wang; Giorgio Scarpellini; Bronwyn Gunn; Wei Xin; Soo-Young Wanda; Kenneth L Roland; Roy Curtiss
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-29       Impact factor: 11.205

10.  Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.

Authors:  S E Leary; E D Williamson; K F Griffin; P Russell; S M Eley; R W Titball
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more
  6 in total

1.  Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.

Authors:  Wei Sun; Shilpa Sanapala; Hannah Rahav; Roy Curtiss
Journal:  Vaccine       Date:  2015-10-26       Impact factor: 3.641

2.  LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.

Authors:  Wei Sun; Shilpa Sanapala; Jeremy C Henderson; Shandiin Sam; Joseph Olinzock; M Stephen Trent; Roy Curtiss
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

Review 3.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.

Authors:  Shilpa Sanapala; Hannah Rahav; Hetal Patel; Wei Sun; Roy Curtiss
Journal:  Vaccine       Date:  2016-04-06       Impact factor: 3.641

5.  Temperature-dependence of yadBC phenotypes in Yersinia pestis.

Authors:  Annette M Uittenbogaard; Tanya Myers-Morales; Amanda A Gorman; Erin Welsh; Christine Wulff; B Joseph Hinnebusch; Timo K Korhonen; Susan C Straley
Journal:  Microbiology (Reading)       Date:  2013-11-12       Impact factor: 2.777

6.  Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated Salmonella enterica Serovar Typhimurium Vaccine Strains.

Authors:  Paweł Łaniewski; Chang-Ho Baek; Kenneth L Roland; Roy Curtiss
Journal:  mBio       Date:  2017-08-22       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.